BSECompany Update1d ago · 17 Nov 2026, 11:40 am

Presentation to be made at the Analysts/ Investors meet/ Conference Earning call for the half year ended 30th September, 2026.

Star Imaging And Path Lab Ltd · 544482

✦ AI Summary▲ PositiveResults

Star Imaging And Path Lab Ltd has announced its investor presentation for the half year ended September 30, 2026, highlighting an 8% YoY growth in revenue to ₹48.9 crore, with enhanced operational efficiency and capacity utilisation across existing diagnostic centres, and progressing towards a debt-free position.

Analysis Scores

Earnings Impact8/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact9/10
Market Sentiment8/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Star Imaging And Path Lab Ltd - 544482 - Announcement under Regulation 30 (LODR)-Investor Presentation

Attachments (1)

📄

d0e5cb51-96c3-4718-800d-093960b5badb.pdf

pdf

Download →
View document text
Date: 17th November 2026 Listing Compliance Department BSE Limited, Phiroze Jeejeebhoy Towers Dalal Street Mumbai 400 001 Scrip Code: 544482 Scrip Symbol: STARIMAGIN Dear Sir / Ma’am, Reg: Disclosure under Regulation 30(6) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 Sub: Presentation to be made at the Analyst(s) / Investor(s) Meet/ Conference- Earnings Call Pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our intimation dated 10th November, 2026 regarding schedule of Analyst(s)/ Investor(s) Meet /Conference i.e Earnings Call on Wednesday, 18th November, 2026 at 3:00 pm (IST), We are hereby enclosing a copy of Investor Presentation based on the Unaudited (Standalone and Consolidated) Financial Results of the Company for the half year ended September 30, 2026, along with the Limited Review Report thereon. The Investor Presentation are also being made available on the Company’s website at www.Starimaging.in . You are requested to take the above on record. Thanking you. For Star Imaging and Path Lab Limited Md Shadab Khan Company Secretary and Compliance Officer Membership Number: A74659 Encl: As above STAR IMAGING AND PATH LAB LIMITED I N V E S T O R P R E S E N T A T I O N H1 FY27 Earnings Update CONTENTS Performance Company Business Model & snapshot Overview Service Portfolio Growth Technology & Financial Strategy Infrastructure Performance Industry Outlook EXECUTIVE SUMMARY – H1 FY27 Revenue and profitability Return and capital Operations & Network REVENUE RETURN ON CAPITAL EMPLOYED DIAGNOSTIC CENTERS ₹ 48.9 crores 8% 18.5% 26 YoY growth vs 28.6% in FY26 vs 24 in FY26 EBITDA RETURN ON EQUITY TEAM SIZE ₹ 14.1 crores 14.2% 266 vs 23.6% in FY26 vs 236 in FY26 vs ₹17.3 Crs in H1 FY26 EBITDA MARGIN FIXED ASSET TURNOVER B2C REVENUE 29% 3.4x ₹18.2 crores 21% vs 38% in H1 FY26 vs 3.8X in FY26 YoY growth PAT NET DEBT TO EQUITY B2G REVENUE ₹ 7.8 crores (0.1x) ₹ 25.6 crores vs (0.3x) in FY26 vs ₹25.8 Crs in FY26 vs ₹10.0 Crs in H1 FY26 PAT MARGIN CASHFLOW FROM OPERATIONS B2B REVENUE 16.0% ₹ (6.2) crores ₹ 5.2 crores 20% vs 22.2% in H1 FY26 vs ₹23.3 Crs in FY26 YoY growth PERFORMANCE UPDATE AND MANAGEMENT COMMENTARY – H1 FY27 • Growth driven by stronger B2B partnerships, rising B2C activity and improved operational BUSINESS efficiencies across existing centres • Enhanced advanced imaging capabilities through the installation of a high-end 640-slice CT scanner. UPDATES • B2B hospital tie-up network expanded significantly, existing empanelment's grew by 40-45 additional hospitals, taking the total B2B network to 150+ tie-ups • Revenue from Operations grew 8% YoY to ₹48.9 crore in H1 FY27 FINANCIAL • Finance costs reduced by 74% YoY to ₹0.33 crore, reflecting a significant decline in interest expenses HIGHLIGHTS • Progressing towards a debt-free position, with two loans fully repaid • Enhanced operational efficiency and capacity utilisation across existing diagnostic centres, MANAGEMENT supporting organic growth COMMENTARY • Strengthening the B2C contribution to reduce dependence on government receivables and support positive operating cash flows MULTI - CHANNEL BUSINESS MODEL B2B B2C TOTAL 21% +8% +20% 18.2 25.8 25.6 48.9 15.0 45.2 H1 FY26 H1 FY27 H1 FY26 H1 FY27 H1 FY26 H1 FY27 H1 FY26 H1 FY27 REVENUE CONTRIBUTION (%) H1 FY26 H1 FY27 One businesses was classified under B2C 10% 11% in the previously published data; that business has been correctly reclassified 52% B2C 33% 57% B2B under B2B in the current presentation. Note: B2G represents government and PPP-based diagnostic services; B2B includes services delivered through hospital and healthcare-provider tie-ups; and B2C comprises direct-to-patient diagnostic services. SERVICE - WISE REVENUE BIFURCATION FY26 H1 FY26 H1 FY27 0% 3% 0% 2% 0% 2% 0% 0% 0% 14% 14% 16% 83% 83% Radiology Pathology Neurology Cardiology Urology Industry FY26 H1 FY26 H1 FY27 YoY Change Radiology 73.6 37.4 39.7 6% Pathology 12.3 6.5 7.6 17% Cardiology 2.2 1.1 1.3 22% Neurology 0.4 0.2 0.2 20% Urology 0.1 0.0 0.1 47% Total 88.5 45.2 48.9 8% GEOGRAPHIC DIVERSIFICATION: EXPANDING REGIONAL FOOTPRINT DELHI UTTAR PRADESH NASHIK H1 FY27 revenue: ₹24.9 crores H1 FY27 revenue: ₹22.4 crores H1 FY27 revenue: ₹1.7 crores Consistent revenue share above 45% Services offered through royalty-based Strong PPP-based radiology services over FY23-FY26 B2G model 7 Centers 18 Centers 1 Center 24.9 22.4 23.7 19.9 H1 FY26 H1 FY27 H1 FY26 H1 FY27 H1 FY26 H1 FY27 CONTENTS Performance Company Business Model & snapshot Overview Service Portfolio Growth Technology & Financial Strategy Infrastructure Performance Industry Outlook STAR IMAGING AND PATH LAB LIMITED: COMPREHENSIVE TESTING UNDER ONE ROOF Star Imaging and Path Lab Limited is a NABL-accredited diagnostic services provider, offering comprehensive pathology, radiology, cardiology, and neurology services in Delhi, Uttar Pradesh and Maharashtra (Nasik). The Company operates in B2C, B2B and B2G model, through an integrated service network to meet diverse diagnostic needs. The Company strategically expanded by acquiring the businesses of Janta X-Ray Clinic, M/s Star Imaging & Path Lab, and M/s Star Health Care in 2011, thereby strengthening its footprint and service capabilities. KEY FACTS: NABHACCREDITATION, INCORPORATED 26 TEAM SIZE ISO15189:2012, IN 2004 DIAGNOSTIC CENTRES 266 NABLACCREDITATION 7.1 LAKH H1 FY27 (IN ₹CRORES) TEST CONDUCTED REVENUE: 48.9 EBITDA: 14.1 FY26 ROCE: 18.5% B2G ReveNUE (FY26) PAT: 7.8 DIVERSE AND EXPERIENCED LEADERSHIP TEAM MR. PAWAN GUPTA DR. SAMEER SOOD Chairman & Managing Director Non-Executive Director Mr. Pawan Gupta, Chairman and Managing Director of Star Imaging and Dr. Sameer Sood, Non-Executive Director of Star Imaging and Path Lab Path Lab Limited, has run family diagnostic business established by his Limited, is a radiologist with experience in conventional and advanced father, Mr. Ram Avtar Gupta. Through the addition of modern technology, imaging techniques, including CT and MRI. He possess degree of Bachelor financial management, and understanding of market dynamic he has of Medicine & Bachelor of Surgery in the Year 1986 and Doctor of Medicine improved service and expanded the operations of their radiology and in Radio- Diagnosis in the year 1989 from All India Institute of Medical pathology center. He has done Bachelor in Commerce from Dr. Bhimrao Sciences (AIIMS). He is having 28 years of association with the Issuer Ambedkar University in year 2000. Company as senior consultant Radiology. MS. NEELAM RATRA MS. CHHAYA GUPTA Executive Director Executive Director Ms. Neelam Ratra, is the Executive Director of Star Imaging and Path Lab Ms. Chhaya Gupta, Director of Star Imaging and Path Lab Limited, looks Limited. She holds a Master’s degree in Business Administration with a into the Human Resource and operational activities of the Company. She specialization in Hospital Administration and Healthcare Management has done Master of Business Administration in International Business from the Delhi Institute of Management Studies, obtained in 2014. Ms. Management from Mewar University in 2014. She is having an experience Ratra has over 5+ years of experience in the healthcare sector and was of 7.5 years for managing the Administration department previously associated with Ayushman Hospital and Healthcare Services. She has been serving as the General Manager of the Issuer Company since July 01, 2024 and further designated as Executive Director. Currently, she is responsible for overseeing the customer relations, digital marketing and overall functioning of the Company. CONTENTS Performance Company Business Model & snapshot Overview Service Portfolio Growth Technology & Financial Strategy Infrastructure Performance Industry Outlook STRATEGIC MOAT : DEFENSIBLE MARKET POSITION 01 02 03 04 Scalable hub-and-spoke Long-standing brand with Strong B2G PPP expertise mo [Showing first 8,000 characters — download PDF for full document]